Vasoactive intestinal polypeptide modulation of nicotinic ACh receptor channels in rat intracardiac neurones.

1. The effects of vasoactive intestinal polypeptide (VIP) on isolated parasympathetic neurones of rat intracardiac ganglia were examined under voltage clamp using dialysed and perforated patch whole‐cell and excised outside‐out membrane patch recording configurations. 2. VIP reversibly potentiated nicotinic ACh‐evoked whole‐cell currents, with half‐maximal potentiation (EC50) obtained with 260 pM VIP. However, VIP had no effect on muscarinic ACh‐evoked currents, ATP‐evoked currents, or depolarization‐activated ionic currents in these neurones. 3. VIP‐induced potentiation of nicotinic ACh‐evoked whole‐cell currents was observed following cell dialysis, and was inhibited reversibly by bath application of the VIP receptor‐binding inhibitor L‐8‐K (5 microM) or the neuronal nicotinic receptor antagonist mecamylamine (3 microM). 4. The signal transduction pathway mediating VIP‐induced potentiation of nicotinic ACh‐evoked currents involves a guanine nucleotide‐binding protein (G‐protein) but not cyclic AMP. Intracellular application of 100 microM GDP‐beta‐S, or pre‐incubation of neurones with pertussis toxin, inhibited VIP‐induced potentiation of ACh‐evoked whole‐cell currents. 5. In outside‐out membrane patches, co‐application of ACh (4 microM) and VIP (4 nM) decreased the duration of closings between bursts and clusters of bursts of ACh single‐channel activity relative to control (4 microM, ACh alone). VIP, however, did not alter single ACh receptor channel current amplitude, duration of closings and openings within a burst, or mean burst duration. 6. VIP‐induced modification of nicotinic ACh receptor channel kinetics results in an increase in the open‐channel probability which is sufficient to account for the VIP‐mediated potentiation of nicotinic ACh‐evoked whole‐cell currents. 7. The potentiation of nicotinic ACh‐evoked currents by VIP is likely to account for the altered neuronal activity observed in the mammalian intracardiac ganglia in vivo and consequent changes in heart rate and cardiac contractility.

[1]  D Colquhoun,et al.  Mechanisms of activation of muscle nicotinic acetylcholine receptors and the time course of endplate currents. , 1995, Annual review of physiology.

[2]  S. Ikeda,et al.  VIP inhibits N-type Ca2+ channels of sympathetic neurons via a pertussis toxin-insensitive but cholera toxin-sensitive pathway , 1994, Neuron.

[3]  D. Gurantz,et al.  VIP modulates neuronal nicotinic acetylcholine receptor function by a cyclic AMP-dependent mechanism , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  David John Adams,et al.  Local anaesthetic blockade of neuronal nicotinic ACh receptor‐channels in rat parasympathetic ganglion cells , 1994, British journal of pharmacology.

[5]  I. Cohen,et al.  Actions of vasoactive intestinal peptide and neuropeptide Y on the pacemaker current in canine Purkinje fibers. , 1994, Circulation research.

[6]  G. Hanson,et al.  Release of vasoactive intestinal peptide and neuropeptide Y from canine heart. , 1993, The American journal of physiology.

[7]  J. Armour,et al.  Peptidergic modulation of in situ canine intrinsic cardiac neurons , 1993, Peptides.

[8]  J. A. Dani,et al.  Nicotinic acetylcholine receptors are directly affected by agents used to study protein phosphorylation. , 1992, Journal of neurophysiology.

[9]  B. Madsen,et al.  Naltrexone modulation of nicotinic acetylcholine receptor activity. , 1991, The Journal of pharmacology and experimental therapeutics.

[10]  D Colquhoun,et al.  Conductance and kinetic properties of single nicotinic acetylcholine receptor channels in rat sympathetic neurones. , 1991, The Journal of physiology.

[11]  Kim Cooper,et al.  Low access resistance perforated patch recordings using amphotericin B , 1991, Journal of Neuroscience Methods.

[12]  David John Adams,et al.  Acetylcholine‐evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia. , 1991, The Journal of physiology.

[13]  J. Polak,et al.  Peptide-containing nerve fibres in guinea-pig coronary arteries: immunohistochemistry, ultrastructure and vasomotility. , 1990, Journal of the autonomic nervous system.

[14]  Y. Furukawa,et al.  Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. , 1990, European journal of pharmacology.

[15]  David John Adams,et al.  Neurotransmission in neonatal rat cardiac ganglion in situ. , 1990, The American journal of physiology.

[16]  G. Burnstock,et al.  M1 and M2 muscarinic receptors mediate excitation and inhibition of guinea‐pig intracardiac neurones in culture. , 1990, The Journal of physiology.

[17]  G. Aghajanian,et al.  Excitation of locus coeruleus neurons by vasoactive intestinal peptide: evidence for a G-protein-mediated inward current , 1989, Brain Research.

[18]  D. Hoover.  Effects of guinea pig vasoactive intestinal peptide on the isolated perfused guinea pig heart , 1989, Peptides.

[19]  D. Rigel.  Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT. , 1988, The American journal of physiology.

[20]  A. Couvineau,et al.  Molecular Analysis of Vasoactive Intestinal Peptide Receptors: A Comparison with Receptors for VIP‐Related Peptides , 1988, Annals of the New York Academy of Sciences.

[21]  P. Brehm,et al.  Vasoactive intestinal peptide activates Ca2+ -dependent K+ channels through a cAMP pathway in mouse lacrimal cells , 1988, Neuron.

[22]  A. Gilman,et al.  G proteins: transducers of receptor-generated signals. , 1987, Annual review of biochemistry.

[23]  G. Rosselin.  The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity , 1986, Peptides.

[24]  T. Akasu,et al.  Vasoactive intestinal polypeptide depolarizations in cat bladder parasympathetic ganglia. , 1986, The Journal of physiology.

[25]  W. D. de Groat,et al.  Depolarization and muscarinic excitation induced in a sympathetic ganglion by vasoactive intestinal polypeptide. , 1985, Science.

[26]  N. Dun,et al.  Vasoactive intestinal polypeptide facilitates muscarinic transmission in mammalian sympathetic ganglia , 1984, Neuroscience Letters.

[27]  K L Magleby,et al.  Burst kinetics of single calcium‐activated potassium channels in cultured rat muscle. , 1983, The Journal of physiology.

[28]  M. Costa,et al.  Vasoactive intestinal peptide-like immunoreactivity in nerves associated with the cardiovascular system of guinea-pigs , 1983, Neuroscience.

[29]  Alan G. Hawkes,et al.  The Principles of the Stochastic Interpretation of Ion-Channel Mechanisms , 1983 .

[30]  J. Lundberg.  Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies. , 1981, Acta physiologica Scandinavica. Supplementum.

[31]  E. Neher,et al.  Single acetylcholine-activated channels show burst-kinetics in presence of desensitizing concentrations of agonist , 1980, Nature.

[32]  Bernard Katz,et al.  Interaction at end-plate receptors between different choline derivatives , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.